Abstract Background Massive fetomaternal hemorrhage can lead to significant fetal morbidity or mortality. RhD negative patients require appropriate treatment to prevent alloimmunization in subsequent pregnancies. Few cases with follow‐up into future pregnancies have been reported.
Sajjad Hassan +4 more
wiley +1 more source
A global survey of blood transfusion practices for patients with sickle cell disease
Abstract Background Sickle cell disease (SCD) affects over 7 million people globally, with blood transfusion remaining a cornerstone of management. However, contemporary transfusion practices across diverse settings remain poorly characterized. We evaluated global transfusion practices for patients with SCD to identify gaps and inform resource ...
Jeremy W. Jacobs +18 more
wiley +1 more source
Modifying quality and equity of care: emerging roles of genetic disease modifiers in β-hemoglobinopathies. [PDF]
Papasavva PL +9 more
europepmc +1 more source
Hemoglobinopathies and Thalassemia in Northeast India: A Scoping Review of Disease Burden, Mutation Spectrum, and Gaps in Molecular Genetic Evidence. [PDF]
Pathak MS +4 more
europepmc +1 more source
Prevalence and Pattern of Hemoglobinopathies Among Women of Reproductive Age Attending a Tertiary Care Center in Central Uttar Pradesh: A Prospective Observational Study. [PDF]
Khan H +6 more
europepmc +1 more source
Rheumatoid arthritis in patients with hemoglobinopathies
Rheumatoid arthritis (RA) in patients suffering from hemoglobinopathies is an important clinical problem, but the correlation between these diseases is still imperfectly known.
Pliakou, X. I. +5 more
core
Beta Thalassemia and Chronic Myeloid Leukemia: Dual Diagnosis Under the Microscope
International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 931-933, October 2026.
Paige Muir +3 more
wiley +1 more source
Registry and Surveillance System for Hemoglobinopathies (RuSH) [PDF]
CS217122-APublication date from document properties.RuSHfactsheet2010.pdfWhat are Hemoglobinopathies? -- What is RuSH? -- What are the goals of RuSH? -- What type of information will be collected? -- How will the information collected benefit people with
core
Coinheritance of non‐deletional hemoglobin H disease with sickle cell trait
Veroniki Komninaka +1 more
doaj +1 more source
Alternative conditioning regimens for hemoglobinopathy gene therapy: balancing efficacy, toxicity, and the next frontier. [PDF]
Sharma A, Corbacioglu S.
europepmc +1 more source

